Industry News
Pharmaceutical Industry News
University of Oxford links up with Evox Therapeutics
Collaboration will focus on developing exosome therapeutics for rare diseases
AZ’s Brilinta reduced rate of stroke and death in high-risk subgroup
New analysis of prespecified subgroup comes from phase III THALES trial
EU signs COVID-19 vaccine deal with CureVac
Initial purchase includes 225 million doses of mRNA-based vaccine
Americans Are More Willing to Take a Coronavirus Vaccine, Poll Suggests
The Gallup survey held promise for an eventual vaccine rollout, but its authors cautioned that confidence remained lower than it was earlier in the pandemic.
New inquiry launched to assess impact of pandemic on pharmacy services
MPs launch inquiry with view of securing extra support for sector
Lead Pharma and Roche enter €260m collaboration agreement
Companies will develop oral small molecule treatments
Gilead and Novo Nordisk’s NASH trial meets primary endpoint
Drug combinations tested were found to be well tolerated
UK strikes deal for five million doses of Moderna’s COVID-19 vaccine
Initial interim data suggests vaccine is 94.5% effective
Does Remdesivir Actually Work Against Covid-19?
The evidence shows only that the drug might be effective. That once wasn’t enough for F.D.A. approval.
Moderna asegura que su vacuna para la COVID-19 tiene una efectividad del 94,5 por ciento
Moderna es la segunda compañía que informa de los resultados preliminares de un gran ensayo de una vacuna. Pero todavía faltan meses para que esté ampliamente disponible para el público.
Learning from history: How government price setting and other anti-innovation policies negatively impact biopharmaceutical R&D
Today, America leads the world in medical innovation because of our unique research ecosystem, but that wasn’t always the case. A new paper from NDP Analytics, “Will US Leadership in Biopharmaceutical R&D Continue? Consequences of
States Vow Extra Scrutiny of Coronavirus Vaccine
Special committees, mostly in Democratic-led states, will seek to reassure the public that an F.D.A.-approved vaccine is safe and effective amid doubts about the Trump administration’s virus response.
Early Data Show Moderna’s Coronavirus Vaccine Is 94.5% Effective
Moderna is the second company to report preliminary results from a large trial testing a vaccine. But there are still months to go before it will be widely available to the public.
NHS launches 40 ‘long COVID’ clinics
It is hoped that the move will help to tackle the persistent symptoms – such as fatigue and brain fog – suffered by people who have developed the condition
The Week in Business: The Vaccine Boost
Markets rallied around promising vaccine trials, but soaring infection rates show that the worst may be yet to come.
Deep dive: The issues that drove the 2020 vote
The 2020 election provided much-needed clarity on the issues that matter most to Americans. Here are three key takeaways:
When Medicare Choices Get ‘Pretty Crazy,’ Many Seniors Avert Their Eyes
A new study shows that more than half of enrollees don’t review or compare their coverage options annually.
Understanding the emergency use authorization process for COVID-19 vaccines
As the world continues to feel the impact of the COVID-19 pandemic, the biopharmaceutical industry is working around the clock to develop safe and effective vaccines to prevent infection, as well as new therapies to treat the
Guest Post: Recognizing America’s Veterans
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest contributors, including patients, stakeholders, innovators and others,
Merck scraps Keytruda lung cancer trial adding Bristol Myers’ Yervoy. What about the Opdivo combo?
Merck scraps Keytruda lung cancer trial adding Bristol Myers' Yervoy. What about the Opdivo combo? aliu Tue, 11/10/2020 - 11:15